DavidPerlmutterMD · 2025-02-10 · David Perlmutter (host), Austin Perlmutter

Is Lifting Weights the Best Dementia Prevention? Muscle’s Impact on Brain Health | Dr. Perlmutter

44 research-tied claims examined: 1 contradicted 2 overstated 4 context 32 supported 5 unverified

Needs context

0:04:39 Austin Perlmutterneeds contextmoderate

Muscles are the primary source of heat in the human body.

"Your muscles are attached to bones by tendons. They're the primary source of your body's heat, and you have three major types of muscles." (said at 0:04:39)

The claim is roughly accurate but requires physiological context. Under resting, thermoneutral conditions (basal metabolic rate), internal organs (such as the liver, brain, heart, and kidneys) produce the majority (approximately 60–70%) of core body heat, while resting skeletal muscle contributes roughly 20–30%. However, during physical activity, exercise, cold exposure, or shivering thermogenesis, skeletal muscle becomes the predominant source of heat production in the human body, generating up to 80–90% of total metabolic heat.

context: Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism. (Diabetes & metabolism journal 2017) · cited 239x in the literature
"skeletal muscle is the largest organ and a major contributor to basal metabolic rate and increasing energy expenditure in muscle through nonshivering thermogenic mechanisms, which can substantially affect whole body metabolism and weight gain." (abstract, passage verified)
pubmed full study (doi)
context: Shivering and nonshivering thermogenesis in skeletal muscles. (Handbook of clinical neurology 2018) · cited 99x in the literature
"As in other large mammals, skeletal muscles are the primary source of heat production recruited in cold-exposed humans. This is achieved voluntarily in the form of contractions from exercising muscles or involuntarily in the form of contractions from shivering muscles and the recruitment of nonshivering mechanisms." (abstract, passage verified)
pubmed full study (doi)

0:37:11 Austin Perlmutterneeds contexthigh

SSRIs have a side effect rate of approximately 50% and a withdrawal/discontinuation effect rate of approximately 50%.

"the side effect rates are 50%, and the withdrawal effects are 50%" (said at 0:37:11)

The speaker's estimates of approximately 50% for both side effect and withdrawal/discontinuation rates are roughly consistent with unadjusted incidence figures reported in systematic reviews, but require qualification regarding placebo-subtracted rates and symptom severity. For antidepressant withdrawal/discontinuation symptoms, systematic reviews and meta-analyses report overall unadjusted incidence rates between 31% and 56%. Specifically, a 2025 meta-analysis found a pooled withdrawal incidence of 42.9% overall and 45.6% for SSRIs, while a 2019 review reported a weighted average incidence of 56%. However, when accounting for placebo responses (nocebo effects and non-specific symptoms), a 2024 meta-analysis estimated that the net drug-attributable incidence of discontinuation symptoms is approximately 15%. For side effects, a 2023 network meta-analysis of SSRIs and SNRIs found that 80.2% of patients in medication groups reported at least one adverse event (compared to 71.2% in placebo groups). Thus, while crude incidence rates in clinical studies align with ~50% estimates, clinical interpretation requires distinguishing total reported symptom rates from net drug-attributable effects.

supports: A systematic review into the incidence, severity and duration of antidepressant withdrawal… (Addictive behaviors 2019) · cited 394x in the literature
"Withdrawal incidence rates from 14 studies ranged from 27% to 86% with a weighted average of 56%." (abstract, results, passage verified)
pubmed full study (doi)
supports: Incidence of adverse events and comparative tolerability of selective serotonin reuptake i… (Psychological medicine 2023) · cited 28x in the literature
"Participants in medication groups presented higher rates of adverse events (80.22%, 95% CI 76.13-83.76) when compared to placebo groups (71.21%, 67.00-75.09)." (abstract, results, passage verified)
pubmed full study (doi)
context: Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysi… (The lancet. Psychiatry 2024) · cited 96x in the literature
"Incidence of at least one antidepressant discontinuation symptom was 0·31 (95% CI 0·27-0·35) in 62 study groups after discontinuation of antidepressants, and 0·17 (0·14-0·21) in 22 study groups after discontinuation of placebo... Considering non-specific effects, as evidenced in placebo groups, the incidence of antidepressant discontinuation symptoms is approximately 15%" (abstract, results and conclusions, passage verified)
pubmed full study (doi)
supports: Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and syst… (Molecular psychiatry 2025) · cited 32x in the literature
"The pooled incidence of AWS from all available studies was 42.9%, from 11 RCTs was 44.4%... The incidence in selective serotonin-norepinephrine reuptake inhibitors was the lowest (29.7%), followed by selective serotonin reuptake inhibitors (45.6%) and tricyclic antidepressants (59.7%), without significant differences (p = 0.221)." (abstract, results)
pubmed full study (doi)

0:45:55 Austin Perlmutterneeds contextmoderate

Approximately 6% of the body's total creatine stores are located in the brain.

"and creatine is primarily stored in your muscles. There's a little bit, around 6%, stored in your brain." (said at 0:45:55)

The speaker correctly identifies that creatine is predominantly stored in skeletal muscle with a small fraction in the brain. However, established physiological literature indicates that approximately 95% of total body creatine is stored in skeletal muscle, while the remaining ~5% is distributed across several tissues with high metabolic demand, including the brain, heart, kidneys, and testes. Therefore, the brain alone does not store ~6% of total body creatine, but rather represents a fraction of the non-muscular ~5% pool.

context: Effects of Creatine Supplementation on Brain Function and Health. (Nutrients 2022) · cited 142x in the literature
"While the vast majority of research involving creatine supplementation has focused on skeletal muscle, there is a small body of accumulating research that has focused on creatine and the brain." (abstract, background, passage verified)
pubmed full study (doi)

0:49:15 David Perlmutter (host)needs contextvery low

DHA acts as a COX-2 inhibitor and directly enhances BDNF (brain-derived neurotrophic factor) production.

"The other thing about DHA is that it does a couple of other things. It's a COX-2 inhibitor, so it reduces inflammation, but it directly also enhances the production of BDNF." (said at 0:49:15)

Preclinical in vitro and animal models demonstrate that docosahexaenoic acid (DHA) can downregulate cyclooxygenase-2 (COX-2) expression, reduce pro-inflammatory prostanoid synthesis by competing with arachidonic acid, and upregulate brain-derived neurotrophic factor (BDNF) levels (often via CREB signaling). However, classifying DHA simply as a 'COX-2 inhibitor' is an oversimplification of its broad lipid mediator and membrane-modulatory mechanisms, and the direct enhancement of BDNF production has primarily been characterized in experimental rodent and cellular models rather than established as a direct therapeutic effect in human clinical trials.

supports: Effects of Low Phytanic Acid-Concentrated DHA on Activated Microglial Cells: Comparison wi… (Neuromolecular medicine 2018) · cited 8x in the literature
"Low PhA-concentrated DHA also decreased COX-2, IL-6, iNOS, GtPx, GtRd, and SOD-1 protein expression when compared to DHA (PhA:500). Furthermore, low PhA-concentrated DHA increased BDNF protein expression in comparison to DHA (PhA:500)." (abstract, results, passage verified)
pubmed full study (doi)
supports: Protective effects of docosahexaenoic acid supplementation on cognitive dysfunction and hi… (Naunyn-Schmiedeberg's archives of pharmacology 2024) · cited 5x in the literature
"Moreover, DHA increased CREB phosphorylation and BDNF levels and attenuated neuroinflammation and oxidative stress, reflected by lower levels of IBA-1, IL-1β, and IL-6 and increased levels of SOD1 and Nrf2." (abstract, results, passage verified)
pubmed full study (doi)

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.